Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PROFID

Financiado

Implementation of personalised risk prediction and prevention of sudden cardiac...

Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction Sudden cardiac death (SCD) is a major public health problem accounting for ~20% of all deaths in Europe with an estimated yearly incidence of ~350-700,000, often in patients with previous myocardial infarction (MI). In SCD, the he... ver más

31/12/2024

CHARITE UNIVERSIT...

23M€

Presupuesto del proyecto: 23M€

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 29 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-12-31

SC1-BHC-25-2019: Demonstration pilots for implementa...

I+D

Cerrada hace 6 años

0% 86% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

29 Participantes

CHARITE UNIVERSITAETSMEDIZI...

6.09M€ | Lider

PALACIOS REFRIGERADOS

AUH

135.00K€ | Participante

SEMMELWEIS UNIVERSITY

185.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RTC-2015-3515-1 ADAS - CARACTERIZACIÓN AUTOMÁTICA DEL SUSTRATO ARRÍTMICO Y E... 175K€ Cerrado

PID2021-128972OA-I00 ESTRATIFICACION DEL RIESGO DE MUERTE SUBITA EN PACIENTES ISQ... 122K€ Cerrado

COMBINE-CT Combining CT diagnostic data and interventional approaches f... 10M€ Cerrado

DPI2016-75799-R TECNOLOGIAS COMPUTACIONALES PARA LA OPTIMIZACION DE TERAPIAS... 122K€ Cerrado

PID2019-104356RB-C41 MODELO MULTIESCALA DE PATOLOGIAS CARDIACAS Y OPTIMIZACION DE... 198K€ Cerrado

TEC2008-02090 MODELO MULTI-ESCALA DEL CORAZON. APLICACION EN LA PREVENCION... 271K€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2019-12-13
Fecha Fin: 2024-12-31

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 23M€

Descripción del proyecto Sudden cardiac death (SCD) is a major public health problem accounting for ~20% of all deaths in Europe with an estimated yearly incidence of ~350-700,000, often in patients with previous myocardial infarction (MI). In SCD, the heart suddenly and unexpectedly stops beating. If untreated, the patient dies within minutes, but SCD can be successfully prevented by an implantable cardioverter-defibrillator (ICD). The ICD is highly effective, but is associated with potentially severe complications and high healthcare costs. Based on historical evidence, guidelines recommend prophylactic ICD implantation in post-MI patients with left ventricular ejection fraction (LVEF)≤35% to prevent SCD. However, only a minority of these patients will ever need the device. In addition, in absolute numbers the majority of SCD cases occurs in patients with LVEF>35% who are currently not considered for prophylactic ICD. Due to the inherent risks and considerable health care expenditures, a personalised treatment approach for ICD implantation is urgently required. Using state-of-the-art methods and large clinical datasets from established international cohorts and registries across different European geographies, PROFID will develop a clinical decision support tool (risk score) to predict the individual SCD risk and identify those post-MI patients that will optimally benefit from an ICD. Two parallel randomised clinical trials will validate implementation of the risk score to determine ICD implantation, while health economic analyses will assess its economic impact on health care systems. A software tool for clinical use of the risk score will be implemented, and a pilot run in 3 European regions with participation of insurance companies and authorities. The unique composition of the consortium with key opinion leaders, patient organisations, large hospital chains, payers, policy makers and state authorities across Europe, will ensure implementation into routine clinical practice.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores